4D Molecular Therapeutics FDMT
NASDAQ FDMT
$12.99 +0.53 (+4.25%)
At close: Nov 11, 2026 · 4:00 PM EST

4D Molecular Therapeutics (FDMT) Intangibles (2022 - 2025)

Updated

Analysis

4D Molecular Therapeutics (FDMT) Intangibles (2022 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Intangibles (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn 18.08 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn 46.65 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn 56.65 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn 24.48 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn - 11.80 Bn
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn 38.15 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn 19.54 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn 13.42 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn 45.96 Bn
10 4D Molecular Therapeutics 875.59 Mn -584.35 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 618.00
Dec 31, 2024 689.00
Dec 31, 2023 1,014.00
Dec 31, 2022 1,092.00
API Access

4D Molecular Therapeutics Intangibles API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=intangibles&ticker=FDMT&period=max&api_key=YOUR_API_KEY